Rule 3701-3-10 | Approval of human immunodeficiency virus tests.
(A) In approving tests to be used to determine whether an individual has human immunodeficiency virus infection under division (B)(1) of section 3701.241 of the Revised Code, the director of health shall consider:
(1) Whether the test has been approved by the United States food and drug administration.
(2) The recommendations of the United States centers for disease control and prevention.
(B) The director shall define a confirmed positive test result as:
(1) Two or more reactive enzyme immunoassay tests;
(2) A positive culture of the human immunodeficiency virus;
(3) A positive reaction to an human immunodeficiency virus antigen test licensed by the United States food and drug administration;
(4) Identification of the human immunodeficiency virus by the use of nucleic acid amplification probe to detect the presence of human immunodeficiency virus;
(5) The director may define other confirmed positive test results after consideration of the recommendations of the United States centers for disease control and prevention.
(C) In developing guidelines for interpreting test results, the director shall consider interpretation criteria established by the United States centers for disease control and prevention.